Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones
US6579862B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 30, 1999 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Mar 30, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J13/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I): containing at least one olefinic bond in or on their D-ring for the treatment of hyperlipidemic and hyperglycemic conditions in mammals wherein X═OH or O and the olefinic bonds are at 4(5); 5(6); 16(17); or 17(20) or various combinations, and wherein the compounds contain at lest one olefinic bond in or on their D-ring. The method comprises administering an effective amount of said compounds to recipient mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.